Lilly €200m expansion of Cork site under review
February 13, 2017Manufacturing and Production, Sales and Marketing Eli Lilly, Ireland, cork
Eli Lilly’s planned €200m investment to its manufacturing plant in Kindsdale, County Cork, is now under-review. The expansion would bring …
Ipsen to acquire Sanofi assets in $88 million deal
February 13, 2017Sales and Marketing Boehringer Ingelheim, Prontalgine, Sanofi, ipsen
Ipsen has announced that it is set to enter into a definitive agreement to acquire five consumer healthcare products from …
First-ever approved fertility app more effective than the pill, experts say
February 13, 2017Research and Development, Sales and Marketing contraception
Fertility app Natural Cycles has become the first-ever smartphone application and software solution to be approved by experts as a …
Seattle Genetics’ prospective $2 billion licensing deal not without controversy
February 13, 2017Sales and Marketing Immunomedics, Seattle Genetics, enVio
Immunomedics announced on 10 February that it had entered a licensing agreement with Seattle Genetics for its leading experimental cancer …
Teva’s Vigodman becomes third CEO to leave in 5 years
February 10, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva
Teva has maintained its habit of changing CEOs rather frequently, as Erez Vigodman has left by “mutual agreement”. He becomes …
Thomas Cueni named as new IFPMA Director General
February 10, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing IFPMA
Thomas Cueni has become the new Director General of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and will …
Intelligent Fingerprinting secures £3 million funding for portable drug screening
February 10, 2017Medical Communications, Research and Development Intelligent Fingerprinting, drug testing, nanotechnology
Intelligent Fingerprinting has received a funding boost to market its fingerprint-based drug screening system further. It is the world’s first …
Top Ten most popular articles on Pharmafile.com this week
February 10, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biggest news, biggest stories, top 10, top 10 stories, top stories, top ten
Two of our top five stories this month are about one company in particular – a company that’s having a …
Vital Signs: Partnerships between industry, providers and academia
February 10, 2017Medical Communications Deloitte
Hanno Ronte, life sciences partner at Deloitte, writes upon the opportunities available when a collaborative environment between industry, providers and …
Brexit could delay key drugs to UK patients, ex-MHRA chairman claims
February 10, 2017Medical Communications, Sales and Marketing Cancer, MHRA, brexit
Former UK regulator and ex-chairman of the Medicines and Healthcare products Regulatory Agency (MHRA) Sir Alasdair Breckenridge has warned that …
FDA approves first treatment for Duchenne muscular dystrophy
February 10, 2017Medical Communications, Sales and Marketing Duchenne Muscular Dystrophy, FDA, marathon, marathon pharmaceuticals
The FDA has announced that it has approved Emflaza (deflazacort), developed by Marathon Pharmaceuticals. The treatment will arrive on the …
Three quarters of healthcare companies to invest in big data by 2021
February 9, 2017Medical Communications, Research and Development Big Data, analytics, clinical trials
The latest research by GBI Research suggests that there may be shift towards the use of big data and analytics …
Top five European countries by pharmaceutical spending per capita
February 9, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing European Pharmaceutical, pharmaceutical market, price
With pricing never far from the news and yet more news stories emerging around the inflated prices of certain generics …
Two Phase 3 failures put nail in the coffin for Lundbeck Alzheimer’s drug
February 9, 2017Research and Development, Sales and Marketing Alzheimer's, Lundbeck, idalopirdine
Danish pharma firm Lundbeck has announced the failure of two Phase 3 trials investigating its experimental Alzheimer’s treatment idalopirdine; the …
Antibiotic-resistance being spread from flies to people
February 9, 2017Research and Development Antibiotic-resistant, bacteria, colistin, mcr-1
There has been a raft of news regarding antibiotic-resistance in the last few weeks, from the very good to the …
Sanofi & Regeneron deflect Amgen’s legal marketing block on Praluent
February 9, 2017Manufacturing and Production, Sales and Marketing Amgen, Regeneron, Repatha, Sanofi, praluent
Sanofi and Regeneron have successfully won in a US Court ruling calling for the suspension of the permanent injunction of …
Bayer’s cardiovascular drug races to target in trial
February 9, 2017Research and Development, Sales and Marketing Bayer, Janssen, Xarelto
Bayer has been putting its blood-thinning drug, Xarelto, through its paces in a Phase 3 trial to determine whether it …
Ex-Novartis exec joins Ipsen as President, Head of Specialty Care
February 8, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen
Harout Semerjian has joined French pharma firm Ipsen as President, Head of Specialty Care International Region & Global Franchises, the …
Ipsen names new Head of Global Medical Affairs
February 8, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen
French pharmaceutical firm Ipsen has announced its recruitment of Dr Sotirios Stergiopoulos as its Senior Vice President and Head of …
Artificial Intelligence could take over 250,000 UK roles by 2030
February 8, 2017Medical Communications, Research and Development NHS, artificial intelligence
Ahead of the government’s expected digital strategy publication tomorrow, a new report has been released looking into how AI could …
Latest content
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?
